Some advanced-biofuels firms get revenue from specialty chemicals

12/5/2011 | Wall Street Journal, The

Several next-generation developers of biofuels are entering the low-volume, high-margin market of specialty chemicals, waiting for the costs of advanced biofuels to go down and technologies to improve, analysts and executives said. "Some people think biochemicals are a crutch on the way to fuels," said Jonathan Wolfson, CEO and co-founder of Solazyme. "We haven't thought about it that way in many, many years."

View Full Article in:

Wall Street Journal, The

Published in Brief: